News Medical on MSN2h
Influenza A virus changes shape to evade immune responses
Influenza A virus particles strategically adapt their shape-to become either spheres or larger filaments-to favor their ability to infect cells depending on environmental conditions, according to a ...
Antibodies Market Size, Share & Forecast By 2033
Introduction Therapeutic antibodies are laboratory-engineered proteins designed to replicate the immune system's natural ability to combat dise ...
Drosera Raises $4.75M to Create the Immune System for Ethereum
San Juan, Puerto Rico, February 10th, 2025, Chainwire Drosera, an innovative Ethereum-aligned security automation layer, ...
Impacts7h
Drosera Secures $4.75M to Fortify Ethereum with a Decentralized “Immune System” for Security
Drosera’s innovative approach, modeled as Ethereum’s immune system, enables protocols to delegate security infrastructure to ...
dvm3607h
Biotechnology company announces financial and clinical milestones
Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...
BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA
BioRay Pharmaceutical Co., Ltd. ("BioRay") announced that the National Medical Products Administration (NMPA) has accepted the clinical trial application for its self-developed Class 1 innovative ...
Business Wire10h
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
Omeros Corporation (Nasdaq: OMER) today announced two presentations that will be featured at the 2025 Tandem Meetings – the ...
Le Lézard7h
Q32 Bio Announces Strategic Restructuring to Focus on Advancement of Bempikibart in Patients with Alopecia Areata
Based on continued emergence of bempikibart data from SIGNAL-AA Part A, including strong re-consent rates and patient demand for continued dosing, Company initiating open-label extension in 1H'25; ...